Suppr超能文献

共沉淀法制备肠溶性微丸及其性质考察。

Preparation and characterization of enteric microparticles by coacervation.

机构信息

Department of Pharmacy, Health and Well Being, Faculty of Applied Sciences, University of Sunderland, City Campus, Sunderland, UK.

出版信息

Drug Dev Ind Pharm. 2013 Jul;39(7):1142-51. doi: 10.3109/03639045.2012.725734. Epub 2012 Sep 25.

Abstract

The aim of this study was to produce cinnarizine loaded Eudragit(®) L100-55 microparticles by coacervation technique in order to achieve pH responsive drug release using hydroxypropyl methycellulose (HPMC) as stabilizer. The effect of enteric polymer: HPMC ratio on properties of microparticles was investigated with regard to particle size distribution, morphology, yield, encapsulation efficiency, in vitro drug release profiles and interaction between cinnarizine and Eudragit(®) L100-55. High drug encapsulation efficiency was seen in all microparticles. Particle diameter increased when the enteric polymer content was higher relative to HPMC. In vitro dissolution studies demonstrated that the drug release from the microparticles was dependent upon enteric polymer: HPMC ratio and particle size distribution. At the ratio of at least 3.75:1 of enteric polymer: HPMC, drug release was suppressed most significantly in low pH (hydrochloric acid as medium) while rapid drug release was observed in pH 7.4.

摘要

本研究旨在通过凝聚技术制备桂利嗪载 Eudragit(®) L100-55 微粒,并用羟丙甲纤维素(HPMC)作为稳定剂以实现 pH 响应型药物释放。考察了肠溶聚合物:HPMC 比例对微粒性质的影响,包括粒径分布、形态、产率、包封效率、体外药物释放曲线以及桂利嗪与 Eudragit(®) L100-55 之间的相互作用。所有微粒均显示出较高的药物包封效率。与 HPMC 相比,当肠溶聚合物含量较高时,粒径增大。体外溶出度研究表明,微粒中药物的释放取决于肠溶聚合物:HPMC 的比例和粒径分布。在肠溶聚合物:HPMC 的比例至少为 3.75:1 时,药物在低 pH(盐酸为介质)下的释放受到最显著的抑制,而在 pH7.4 时则观察到快速释放。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验